Team
Our team combines decades of drug development experience, single cell computational biology expertise, and a background in pathogenic cell elimination.
Adam Freund, PhD
Founder & Chief Executive Officer
Dr. Freund has 20 years of experience in life science R&D, focused on blending experimental and computational biology to understand and modulate chronic diseases. He has published >20 papers and patents, which have been cited >10,000 times. Prior to founding Arda, he was a Principal Investigator at Calico Life Sciences, where he helped grow the company from ~15 to 200+ employees and initiated and led multiple therapeutic programs, several of which are now in the clinic.
Remi-Martin Laberge, PhD
Founder and Chief Technology Officer
Dr. Laberge has 20+ years of experience in life science R&D. He is an expert in pathogenic cell elimination, discovered the first senolytic molecules, and has published >50 papers and patents. Prior to Arda, he was Head of Cellular Biology at Unity Biotechnology, where he drove platform development and led multiple teams to clinical stage assets. As part of the foundational team at Unity, he grew the company from inception to >100 employees. He was also previously the VP of Scientific Operations at IRICoR, where he managed a portfolio of >20 early drug discovery programs.